Discontinuation report TEVA-DIVALPROEX

Last updated on 2019-10-26 History
Report ID 97232
Drug Identification Number 02239701
Brand name TEVA-DIVALPROEX
Common or Proper name DIVALPROEX
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) VALPROIC ACID
Strength(s) 125MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL
Packaging size 100
ATC code N03AG
ATC description ANTIEPILEPTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-10-25
Remaining supply date 2019-10-25
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2019-10-26 English Compare
v2 2019-10-25 French Compare
v1 2019-10-25 English Compare